Cohen & Steers
REGN icon

Cohen & Steers’s Regeneron Pharmaceuticals REGN Stock Holding History

Cohen & Steers’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100K Hold
130
– – ﹤0.01% 416
2025
Q4 		$100K Hold
130
– – ﹤0.01% 426
2025
Q3 		$73K Hold
130
– – ﹤0.01% 432
2025
Q2 		$68K Hold
130
– – ﹤0.01% 427
2025
Q1 		$82K Buy
+130
New +$89.4K ﹤0.01% 407

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cohen & Steers's REGN Position: Q1 2026 in Review

Cohen & Steers held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 130 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #416.

Cohen & Steers first reported a position in REGN in Q1 2025 and has held it in 5 quarters since. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Cohen & Steers held 130 shares of Regeneron Pharmaceuticals worth $100K as of Q1 2026.
  • Cohen & Steers left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Cohen & Steers's portfolio in Q1 2026, its #416 holding.
  • Cohen & Steers first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Cohen & Steers's 13F filing for Q1 2026, filed 15 May 2026.